To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene UBA2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
505 supporting clones for gene UBA2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA489971 brain .a 1 to 564 2 to 565   tiling clone, capped   564/565
(99 %)
1 diff
(99.9 %id)
DA510484 brain .a 1 to 571 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA648617   .a 1 to 544 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA952012 Spleen .a 1 to 562 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DB046496 testis .a 1 to 575 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
BG503066 embryonal carcinoma, testis .a 2 to 761 1 to 755       755/761
(99 %)
10 diff
(98.7 %id)
AK023120   .a 3 to 2665 1 to 2663 M97I M128V I637T available from FLJ,   2663/2663
(100 %)
7 diff
(99.8 %id)
DA480951   .a 4 to 534 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
NM_005499.2   .a 4 to 2667 1 to 2664 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2664/2664
(100 %)
0 diff
(100 %id)
DA789326 brain .a 8 to 565 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
DA795292 brain .a 9 to 573 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DB170839 kidney, tumor tissue .a 9 to 583 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
AL545123 placenta, Placenta Cot 25-normalized .a 13 to 982 1 to 970       970/970
(100 %)
0 diff
(100 %id)
DA493287 brain .a 13 to 584 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
AL553584 placenta, Placenta Cot 25-normalized .a 14 to 920 1 to 905       905/905
(100 %)
7 diff
(99.3 %id)
BG259574 embryonal carcinoma, cell line, testis .a 14 to 557 1 to 545       543/545
(99 %)
2 diff
(99.7 %id)
BQ917312 sciatic nerve .a 15 to 803 24 to 821       798/925
(86 %)
19 diff
(98.0 %id)
DA753186   .a 15 to 543 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
AL518887 brain, neuroblastoma, neuroblastoma cells .a 16 to 1089 1 to 1068       1068/1088
(98 %)
25 diff
(97.8 %id)
BX460212 brain, fetal brain .a 16 to 1019 1 to 999       999/1074
(93 %)
9 diff
(99.2 %id)
BI559888 testis .a 17 to 731 1 to 716       716/717
(99 %)
13 diff
(98.2 %id)
BI562623 testis .a 17 to 730 1 to 710       710/1079
(65 %)
18 diff
(98.4 %id)
BG169573 hypernephroma, cell line, Kidney .a 19 to 710 1 to 689       689/692
(99 %)
4 diff
(99.5 %id)
BI461965 testis .a 19 to 766 1 to 747       747/749
(99 %)
7 diff
(99.1 %id)
BQ213486 large cell carcinoma, lung .a 20 to 731 1 to 714       714/926
(77 %)
10 diff
(99.0 %id)
TI_44169404   .a 21 to 659 84 to 730       647/829
(78 %)
19 diff
(97.8 %id)
DA700394   .a 21 to 541 2 to 525   capped   522/524
(99 %)
3 diff
(99.5 %id)
TI_44348368   .a 22 to 731 153 to 863       711/864
(82 %)
15 diff
(98.3 %id)
TI_44351039   .a 22 to 730 128 to 832       705/1201
(58 %)
20 diff
(98.4 %id)
BM751272 Ascites, stomach .a 22 to 608 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
DA533645 brain .a 23 to 598 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA777159 brain .a 23 to 587 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DB499934 hypothalamus .a 24 to 520 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BC003153 Skin, melanotic melanoma. .a 26 to 2665 1 to 2640 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2640/2640
(100 %)
2 diff
(100.0 %id)
AK315521 tongue .a 27 to 1996 1 to 1970 T149A I384V     1970/1970
(100 %)
3 diff
(99.9 %id)
BI560871 testis .a 27 to 761 1 to 737       738/737
(100 %)
11 diff
(98.6 %id)
DA352441 substantia nigra .a 28 to 604 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA387828 thalamus .a 28 to 602 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA387847 thalamus .a 28 to 600 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA554720   .a 28 to 556 2 to 531   capped   530/530
(100 %)
2 diff
(99.7 %id)
DA766724 tongue .a 28 to 580 2 to 556   capped   553/558
(99 %)
4 diff
(99.3 %id)
DA772733 brain .a 28 to 583 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA026547   .a 30 to 607 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA442181 tongue, tumor tissue .a 30 to 608 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BQ889284 epidermoid carcinoma, cell line, salivary gland .a 30 to 816 1 to 798       798/904
(88 %)
21 diff
(97.7 %id)
BG479354 choriocarcinoma, placenta .a 32 to 845 1 to 820       818/820
(99 %)
10 diff
(98.8 %id)
TI_44349107   .a 32 to 761 85 to 816       733/816
(89 %)
13 diff
(98.5 %id)
CN290932 embryonic stem cells, cell lines H1, H7, andH9 .a 33 to 633 1 to 601       601/601
(100 %)
3 diff
(99.6 %id)
DA489154 brain .a 33 to 580 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DB482712 hippocampus .a 36 to 532 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
AF090384   .a 38 to 2667 1 to 2630 S229C L307R AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2630/2630
(100 %)
9 diff
(99.7 %id)
CX754597 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 43 to 807 1 to 765     Submitted on the opposite strand 765/768
(99 %)
6 diff
(99.3 %id)
AF079566 placenta .a 44 to 2664 61 to 2683 S229C L307R     2623/2683
(97 %)
12 diff
(99.6 %id)
CN290920 embryonic stem cells, cell lines H1, H7, andH9 .a 44 to 816 1 to 773       773/773
(100 %)
2 diff
(99.8 %id)
CD558157 testis .a 46 to 918 19 to 903       882/932
(94 %)
39 diff
(95.9 %id)
DB457274 testis .a 47 to 552 1 to 506       506/506
(100 %)
0 diff
(100 %id)
CD171589 testis .a 47 to 886 1 to 842       842/842
(100 %)
6 diff
(99.3 %id)
TI_57163911   .a 47 to 845 20 to 818       799/858
(93 %)
31 diff
(96.4 %id)
CN290923 embryonic stem cells, DMSO-treated H9 cellline .a 48 to 824 1 to 778       778/778
(100 %)
7 diff
(99.2 %id)
AL136905 testis .a 49 to 2665 1 to 2617 E341G available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2617/2617
(100 %)
3 diff
(99.9 %id)
BX438049 neuroblastoma .a 49 to 1085 1 to 1022       1022/1022
(100 %)
17 diff
(98.4 %id)
U35832   .a 49 to 2665 1 to 2617 exact     2617/2617
(100 %)
2 diff
(100.0 %id)
DB477595 hippocampus .a 53 to 527 1 to 475       475/475
(100 %)
2 diff
(99.6 %id)
BU145315 ductal carcinoma, cell line, Pancreas .a 54 to 854 1 to 806       806/902
(89 %)
16 diff
(98.3 %id)
BG392714 embryonal carcinoma, cell line, testis .a 55 to 846 1 to 790       790/898
(87 %)
28 diff
(96.9 %id)
BI834362 pooled pancreas and spleen .a 56 to 845 1 to 791       791/831
(95 %)
25 diff
(97.0 %id)
CN290921 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 60 to 426 1 to 367       367/367
(100 %)
0 diff
(100 %id)
BJ992559 hepatoblastoma .a 60 to 509 1 to 450       450/450
(100 %)
0 diff
(100 %id)
DA957020 Spleen .a 60 to 621 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA262975 caudate nucleus .a 61 to 637 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
CN290928 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 61 to 803 1 to 744       744/744
(100 %)
6 diff
(99.2 %id)
DB447642 testis .a 61 to 496 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
BQ650289 hepatocellular carcinoma, cell line, Liver .a 61 to 820 1 to 775       775/935
(82 %)
26 diff
(97.3 %id)
DA826701 pericardium .a 61 to 625 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA905399   .a 61 to 612 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BP222042   .a 62 to 637 1 to 577       577/582
(99 %)
3 diff
(99.5 %id)
BX419245 brain, fetal brain .a 62 to 952 1 to 903       903/926
(97 %)
15 diff
(98.4 %id)
TI_57163084   .a 62 to 845 63 to 850       788/864
(91 %)
13 diff
(98.5 %id)
BU170630 eye, retinoblastoma .a 63 to 847 7 to 792       786/902
(87 %)
14 diff
(98.5 %id)
DA302197 hippocampus .a 64 to 627 2 to 566   capped   565/566
(99 %)
2 diff
(99.7 %id)
DA491376 brain .a 64 to 634 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA782345 brain .a 64 to 621 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA788233 brain .a 64 to 654 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
BU161773 melanotic melanoma, skin .a 65 to 906 8 to 855       848/868
(97 %)
17 diff
(98.1 %id)
DA518045 brain .a 66 to 619 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BI838445 pooled pancreas and spleen .a 66 to 845 1 to 784       784/798
(98 %)
7 diff
(99.2 %id)
BM473766 melanotic melanoma, skin .a 68 to 726 1 to 661       661/1180
(56 %)
17 diff
(98.6 %id)
BU598295 mixed (pool of 40 RNAs) .a 68 to 847 1 to 782       782/802
(97 %)
12 diff
(98.6 %id)
CN290925 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 69 to 797 1 to 729       729/729
(100 %)
3 diff
(99.6 %id)
BX338537 Placenta Cot 25-normalized .a 69 to 1047 1 to 971       971/972
(99 %)
16 diff
(98.4 %id)
AL039462 testis .a 69 to 664 1 to 596       596/596
(100 %)
0 diff
(100 %id)
BE903218 choriocarcinoma, placenta .a 69 to 847 11 to 790       780/843
(92 %)
15 diff
(98.3 %id)
CX164278 human embryonic stem cells differentiated toan early endodermal cell type .a 69 to 893 1 to 825       825/825
(100 %)
0 diff
(100 %id)
CX785649 human embryonic stem cells .a 69 to 839 1 to 771       771/771
(100 %)
0 diff
(100 %id)
CV806447 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 69 to 723 1 to 656       656/664
(98 %)
7 diff
(99.0 %id)
BX425789 neuroblastoma .a 70 to 847 1 to 778       778/778
(100 %)
2 diff
(99.8 %id)
DR158660 human embryonic stem cells differentiated toan early endodermal cell type .a 70 to 841 1 to 772       772/772
(100 %)
0 diff
(100 %id)
BQ065194 lymph, lymphoma, cell line .a 72 to 771 1 to 706       706/1141
(61 %)
15 diff
(98.7 %id)
TI_1948086373   .a 73 to 960 135 to 1034   AAA   900/1307
(68 %)
35 diff
(97.4 %id)
TI_1948086542   .a 73 to 945 138 to 1025       886/1333
(66 %)
27 diff
(98.0 %id)
TI_1948086719   .a 73 to 844 139 to 911       773/1351
(57 %)
11 diff
(99.2 %id)
TI_1948086892   .a 73 to 945 135 to 1009       875/1288
(67 %)
23 diff
(98.3 %id)
AF110957   .a 74 to 1996 1 to 1923 exact     1923/1923
(100 %)
1 diff
(100.0 %id)
BT009781   .a 74 to 1994 1 to 1921       1921/1923
(99 %)
2 diff
(99.9 %id)
CR456756   .a 74 to 1994 1 to 1921       1921/1923
(99 %)
2 diff
(99.9 %id)
CV026047 mixed .a 74 to 634 1 to 561       561/561
(100 %)
1 diff
(99.9 %id)
BQ889474 dorsal root ganglia .a 76 to 952 1 to 885       885/944
(93 %)
21 diff
(97.8 %id)
BQ898253 dorsal root ganglia .a 77 to 945 1 to 878       878/944
(93 %)
11 diff
(98.9 %id)
CN290926 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 79 to 279 1 to 201       201/201
(100 %)
0 diff
(100 %id)
CN290917 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 80 to 573 1 to 494       494/494
(100 %)
0 diff
(100 %id)
AL041442 testis .a 80 to 636 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BM545672 ovary (pool of 3) .a 80 to 927 1 to 864       862/983
(87 %)
21 diff
(97.9 %id)
BE902679 choriocarcinoma, placenta .a 90 to 847 1 to 765       765/885
(86 %)
32 diff
(96.4 %id)
AW407556 lymph .a 113 to 376 1 to 264       264/264
(100 %)
11 diff
(95.9 %id)
TI_154145949   .a 118 to 654 78 to 620       543/824
(65 %)
32 diff
(96.2 %id)
TI_154147295   .a 118 to 527 95 to 505       411/414
(99 %)
16 diff
(96.2 %id)
BP237016 coronary artery .a 122 to 709 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BJ990529 hepatoblastoma .a 148 to 738 10 to 600       591/600
(98 %)
7 diff
(98.9 %id)
AI124864 brain, pooled frontal lobe .a 153 to 559 1 to 407     Submitted on the opposite strand 407/407
(100 %)
0 diff
(100 %id)
BE898251 adenocarcinoma cell line, ovary .a 153 to 945 1 to 790       790/793
(99 %)
10 diff
(98.8 %id)
AA091966   .a 172 to 507 1 to 329       329/336
(97 %)
20 diff
(94.1 %id)
DA494373 brain .a 176 to 730 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
N40237 melanocyte .a 176 to 561 1 to 388       386/393
(98 %)
3 diff
(99.3 %id)
DA492200 brain .a 177 to 741 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
BQ333448 pnet .a 178 to 575 61 to 459       399/459
(86 %)
15 diff
(96.8 %id)
AW582710 stomach .a 179 to 584 16 to 418       403/427
(94 %)
14 diff
(96.8 %id)
BQ319478 colon .a 179 to 527 360 to 1       358/367
(97 %)
23 diff
(93.8 %id)
BP200305 amygdala .a 182 to 764 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BI047979 stomach .a 185 to 591 14 to 423       410/423
(96 %)
20 diff
(95.3 %id)
BQ328525 leiomios .a 185 to 584 1 to 400       400/409
(97 %)
7 diff
(98.3 %id)
BQ328527 leiomios .a 186 to 584 7 to 405       399/414
(96 %)
11 diff
(97.4 %id)
BQ328524 leiomios .a 189 to 584 20 to 414       395/423
(93 %)
10 diff
(97.7 %id)
AW836712 leiomios .a 194 to 584 14 to 404       391/413
(94 %)
10 diff
(97.6 %id)
AA373795 lung .a 196 to 531 1 to 338       338/349
(96 %)
6 diff
(98.3 %id)
AW364831 denis_drash .a 210 to 770 1 to 565       565/565
(100 %)
19 diff
(96.7 %id)
BI047983 stomach .a 210 to 431 1 to 224       224/225
(99 %)
15 diff
(93.4 %id)
AW364825 denis_drash .a 212 to 298 1 to 86       86/107
(80 %)
5 diff
(95.4 %id)
AW580242 head_neck .a 212 to 578 14 to 374       361/375
(96 %)
15 diff
(96.0 %id)
AW605292 denis_drash .a 214 to 448 1 to 234       234/234
(100 %)
13 diff
(94.5 %id)
AW605307 denis_drash .a 214 to 448 1 to 234       234/234
(100 %)
13 diff
(94.5 %id)
AW606823 head_neck .a 221 to 578 7 to 359       353/360
(98 %)
9 diff
(97.5 %id)
DA685632   .a 221 to 764 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
AW605300 denis_drash .a 223 to 825 1 to 601       601/605
(99 %)
10 diff
(98.4 %id)
AW605315 denis_drash .a 223 to 825 1 to 601       601/605
(99 %)
10 diff
(98.4 %id)
BP269721 thyroid .a 225 to 800 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
AU139782 placenta .a 228 to 965 2 to 739   capped   738/740
(99 %)
5 diff
(99.4 %id)
BF127858 leiomyosarcoma cell line, uterus .a 229 to 831 1 to 603       603/603
(100 %)
12 diff
(98.1 %id)
AW383899 head_neck .a 237 to 828 43 to 635       593/635
(93 %)
12 diff
(98.2 %id)
AW383891 head_neck .a 242 to 510 69 to 337       269/337
(79 %)
8 diff
(97.7 %id)
BG950758 colon .a 244 to 341 7 to 103       97/103
(94 %)
6 diff
(94.2 %id)
AL547474 placenta, Placenta Cot 25-normalized .a 251 to 1194 1 to 944       944/944
(100 %)
2 diff
(99.8 %id)
BP336061 coronary artery .a 260 to 844 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP337608 coronary artery .a 260 to 846 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BP363619 lung .a 260 to 844 1 to 586       586/587
(99 %)
3 diff
(99.5 %id)
BE883810 leiomyosarcoma, uterus .a 261 to 950 1 to 696       696/884
(78 %)
14 diff
(98.5 %id)
BF037200 adenocarcinoma, ovary .a 264 to 939 1 to 674       674/729
(92 %)
7 diff
(99.1 %id)
DB014562 esophageal, tumor tissue .a 266 to 830 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
EH311717   .a 272 to 333 1 to 61       61/61
(100 %)
1 diff
(98.4 %id)
BM907945 large cell carcinoma, lung .a 275 to 1085 14 to 831       818/1037
(78 %)
29 diff
(97.3 %id)
DA886584   .a 284 to 844 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
BP290267 lung .a 312 to 893 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA304076 hippocampus .a 322 to 880 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BM750830 Ascites, stomach .a 331 to 526 1 to 196       196/196
(100 %)
2 diff
(99.0 %id)
DA161280 amygdala .a 334 to 897 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA484669 brain .a 342 to 897 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BP335654 coronary artery .a 351 to 935 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP336162 coronary artery .a 351 to 934 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
BP335690 coronary artery .a 352 to 936 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
AW372230 breast .a 367 to 977 626 to 18       609/671
(90 %)
3 diff
(99.6 %id)
BG150087 carcinoid, lung .a 370 to 567 1 to 198     Submitted on the opposite strand 198/199
(99 %)
10 diff
(95.0 %id)
DA301722 hippocampus .a 387 to 925 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
BU506975 leiomyosarcoma, uterus .a 397 to 1316 45 to 973       929/975
(95 %)
21 diff
(97.9 %id)
DA504116 brain .a 398 to 953 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA485690 brain .a 411 to 978 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA869201 Prostate .a 411 to 934 2 to 525   capped   524/524
(100 %)
1 diff
(99.9 %id)
BP349906 brain .a 411 to 955 1 to 544       544/583
(93 %)
17 diff
(97.1 %id)
BM750823 Ascites, stomach .a 413 to 959 1 to 547       547/547
(100 %)
0 diff
(100 %id)
DA811784 ovary, tumor tissue .a 414 to 1157 2 to 753   capped   752/798
(94 %)
9 diff
(98.9 %id)
BG389676 embryonal carcinoma, cell line, testis .a 416 to 1109 1 to 699       699/971
(71 %)
14 diff
(98.6 %id)
DA088706 cerebellum .a 425 to 981 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
BP194165 brain .a 445 to 1026 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA085957 cerebellum .a 452 to 1013 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA918841 small intestine .a 453 to 988 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
BF794759 lymph, lymphoma, cell line .a 457 to 1201 1 to 750       746/963
(77 %)
26 diff
(97.4 %id)
DB027748 testis .a 477 to 1065 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
BQ218790 leiomyosarcoma, uterus .a 478 to 1457 1 to 981       979/982
(99 %)
11 diff
(98.9 %id)
BE903180 choriocarcinoma, placenta .a 482 to 1112 121 to 750       630/754
(83 %)
12 diff
(98.5 %id)
DB026837 testis .a 484 to 960 2 to 479   capped   478/478
(100 %)
1 diff
(99.8 %id)
DA372253 thalamus .a 490 to 1050 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA603440   .a 521 to 1298 2 to 778   capped   777/777
(100 %)
3 diff
(99.7 %id)
DA783355 brain .a 531 to 1110 2 to 581   capped   580/582
(99 %)
1 diff
(99.9 %id)
CA393607 eye, RPE/choroid .a 537 to 1106 1 to 570       570/570
(100 %)
0 diff
(100 %id)
BF969748 adrenal cortex carcinoma, cell line, adrenal gland .a 539 to 1184 1 to 646       646/646
(100 %)
0 diff
(100 %id)
AV691075 hepatocellular carcinoma .a 553 to 895 1 to 343       343/349
(98 %)
1 diff
(99.8 %id)
BG977404 colon_ins .a 561 to 1112 1 to 551       551/554
(99 %)
3 diff
(99.5 %id)
DA086261 cerebellum .a 568 to 1137 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
BP341403 stomach mucosa .a 571 to 1147 1 to 577       577/577
(100 %)
0 diff
(100 %id)
DA164323 amygdala .a 586 to 1142 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
BE786523 large cell carcinoma, lung .a 590 to 1248 1 to 657       657/659
(99 %)
8 diff
(98.8 %id)
CB116702 Liver .a 601 to 1132 1 to 532       532/532
(100 %)
2 diff
(99.7 %id)
DB016066 esophageal, tumor tissue .a 624 to 1186 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
AU124381   .a 626 to 1416 2 to 794   capped   793/797
(99 %)
15 diff
(98.2 %id)
DA825686 pericardium .a 626 to 1195 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
CB150630 cervix, Uterine .a 632 to 1279 1 to 648       648/648
(100 %)
2 diff
(99.7 %id)
BM460182 leiomyosarcoma, uterus .a 633 to 1479 1 to 855       855/1099
(77 %)
26 diff
(97.7 %id)
BG180742 adenocarcinoma, cell line, Prostate .a 642 to 1317 1 to 675       675/986
(68 %)
6 diff
(99.4 %id)
CD243235 brain, Pituitary .a 647 to 1416 8 to 788       779/940
(82 %)
30 diff
(96.9 %id)
CN290919 embryonic stem cells, cell lines H1, H7, andH9 .a 649 to 1406 5 to 761       757/761
(99 %)
7 diff
(99.1 %id)
DA021405   .a 655 to 1214 10 to 570   capped   561/569
(98 %)
2 diff
(99.7 %id)
DA614204   .a 661 to 1157 2 to 500   capped   499/499
(100 %)
2 diff
(99.6 %id)
BE547075 cervical carcinoma cell line, cervix .a 662 to 1280 1 to 619       619/620
(99 %)
5 diff
(99.2 %id)
BG119063 adenocarcinoma, cell line, Liver .a 669 to 1364 1 to 691       691/978
(70 %)
9 diff
(99.1 %id)
BP370945 testis .a 670 to 1242 1 to 573       573/573
(100 %)
5 diff
(99.2 %id)
BP337446 coronary artery .a 671 to 1253 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BE779762 eye, retinoblastoma .a 678 to 1284 1 to 610       610/819
(74 %)
10 diff
(98.8 %id)
DA052110   .a 686 to 1278 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
DA209663 brain .a 688 to 1269 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
AW246896 lung, small cell carcinoma .a 688 to 763 7 to 83       77/88
(87 %)
7 diff
(92.1 %id)
BE384730 melanotic melanoma, skin .a 700 to 1397 1 to 693       693/793
(87 %)
9 diff
(98.9 %id)
BI223928 cervical carcinoma cell line, cervix .a 732 to 1481 1 to 752       752/799
(94 %)
24 diff
(97.0 %id)
BE874442 large cell carcinoma, undifferentiated, lung .a 754 to 1470 1 to 717       717/864
(82 %)
18 diff
(98.0 %id)
BP243807 Liver .a 757 to 1306 1 to 550       550/550
(100 %)
5 diff
(99.1 %id)
BG574348 breast, mammary adenocarcinoma, cell line .a 763 to 1565 1 to 807       807/807
(100 %)
11 diff
(98.7 %id)
BF968269 adrenal cortex carcinoma, cell line, adrenal gland .a 764 to 1545 1 to 776       776/882
(87 %)
14 diff
(98.5 %id)
BP244353 Kidney .a 782 to 1363 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
TI_59382080   .a 783 to 1469 103 to 801       699/812
(86 %)
23 diff
(97.2 %id)
BQ679568 melanotic melanoma, cell line, skin .a 786 to 1681 1 to 901       901/902
(99 %)
15 diff
(98.4 %id)
BP336259 coronary artery .a 808 to 1388 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CN290918 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 821 to 1574 1 to 757       757/763
(99 %)
5 diff
(99.4 %id)
AK024114 whole embryo, mainly head .a 829 to 2665 1 to 1836   available from FLJ,   1836/1836
(100 %)
5 diff
(99.8 %id)
AU119912 whole embryo, mainly head .a 830 to 1642 2 to 814   capped   813/813
(100 %)
2 diff
(99.8 %id)
AV706730 adrenal gland .a 845 to 1495 1 to 649       649/673
(96 %)
14 diff
(98.0 %id)
DA002757   .a 848 to 1410 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DB024883 testis .a 850 to 1411 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BU940398 mixed (pool of 40 RNAs) .a 854 to 1462 1 to 615       615/682
(90 %)
14 diff
(98.0 %id)
R56996   .a 863 to 1163 1 to 301       301/301
(100 %)
2 diff
(99.4 %id)
CD558709 White Matter .a 876 to 1686 37 to 855       819/932
(87 %)
24 diff
(97.5 %id)
BE908965 epithelioid carcinoma, Pancreas .a 880 to 1574 1 to 699       699/975
(71 %)
9 diff
(99.1 %id)
DA840974 placenta .a 881 to 1452 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
AV647993 corresponding non cancerous liver tissue .a 894 to 1297 1 to 404     Submitted on the opposite strand 404/404
(100 %)
0 diff
(100 %id)
AV649590 corresponding non cancerous liver tissue .a 894 to 1515 1 to 623     Submitted on the opposite strand 623/631
(98 %)
5 diff
(99.3 %id)
DR760956 embryonic stem .a 899 to 1669 1 to 771       771/771
(100 %)
0 diff
(100 %id)
AA307181 colon .a 902 to 1378 1 to 479       479/479
(100 %)
3 diff
(99.4 %id)
CD557600 testis .a 902 to 1679 1 to 788       788/816
(96 %)
16 diff
(98.1 %id)
AW954657   .a 903 to 1521 1 to 620       620/621
(99 %)
7 diff
(98.9 %id)
BE896703 melanotic melanoma, skin .a 907 to 1578 1 to 683       683/1161
(58 %)
25 diff
(97.9 %id)
BE535880 cervix .a 920 to 1563 1 to 646       646/681
(94 %)
10 diff
(98.6 %id)
CX785057 human embryonic stem cells .a 922 to 1283 1 to 362       362/362
(100 %)
0 diff
(100 %id)
DA075394 cerebellum .a 942 to 1503 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
BE088858 breast .a 943 to 1095 179 to 22     Submitted on the opposite strand 158/192
(82 %)
0 diff
(100 %id)
BE088929 breast .a 943 to 1095 179 to 22     Submitted on the opposite strand 158/192
(82 %)
0 diff
(100 %id)
BF762973 colon_est .a 943 to 1387 452 to 9     Submitted on the opposite strand 444/483
(91 %)
0 diff
(100 %id)
BM477166 lymph, lymphoma, cell line .a 943 to 1816 9 to 883       875/1117
(78 %)
21 diff
(98.2 %id)
DA728893   .a 943 to 1792 2 to 851   capped   850/850
(100 %)
9 diff
(99.0 %id)
BG762060 melanotic melanoma, high MDR (cell line), skin .a 950 to 1803 1 to 861       861/867
(99 %)
22 diff
(97.5 %id)
BP368321 thymus .a 952 to 1533 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BM472688 melanotic melanoma, skin .a 967 to 1790 1 to 833       833/943
(88 %)
18 diff
(98.1 %id)
BU173065 eye, retinoblastoma .a 976 to 1868 1 to 898       897/905
(99 %)
11 diff
(98.8 %id)
BF792230 adrenal cortex carcinoma, cell line, adrenal gland .a 980 to 1611 1 to 632       632/634
(99 %)
5 diff
(99.3 %id)
BX350264 Placenta Cot 25-normalized .a 984 to 1814 830 to 1       830/830
(100 %)
1 diff
(99.9 %id)
BP265825 thyroid .a 992 to 1574 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BG257748 embryonal carcinoma, cell line, testis .a 993 to 1764 1 to 769       769/951
(80 %)
13 diff
(98.7 %id)
CB151240 cervix, Uterine .a 997 to 1571 1 to 575       575/576
(99 %)
0 diff
(100 %id)
BQ057522 lymph, lymphoma, cell line .a 998 to 1656 1 to 668       668/1439
(46 %)
21 diff
(98.6 %id)
BP370270 testis .a 1002 to 1574 1 to 572       572/576
(99 %)
9 diff
(98.5 %id)
BF981976 duodenal adenocarcinoma, cell line, small intestine .a 1003 to 1807 1 to 793       793/974
(81 %)
29 diff
(97.1 %id)
CK005578 brain/CNS, Human Brain - Frontal Cortex .a 1003 to 1707 1 to 701       701/701
(100 %)
7 diff
(99.1 %id)
BG621479 placenta .a 1029 to 1690 1 to 662       662/665
(99 %)
1 diff
(99.9 %id)
BQ437513 melanotic melanoma, skin .a 1068 to 1933 12 to 880       869/885
(98 %)
25 diff
(97.2 %id)
BM830585 Ascites, stomach .a 1072 to 1604 1 to 533       533/533
(100 %)
0 diff
(100 %id)
CD521118 pooled .a 1080 to 1776 1 to 704       704/745
(94 %)
11 diff
(98.6 %id)
BM738977 Ascites, stomach .a 1098 to 1543 1 to 443       443/443
(100 %)
3 diff
(99.4 %id)
AB208872 brain .a 1107 to 2665 1 to 1559   tiling clone,   1559/1559
(100 %)
1 diff
(100.0 %id)
TI_1948086543   .a 1110 to 1999 1009 to 122       888/1262
(70 %)
18 diff
(98.6 %id)
TI_1948086720   .a 1111 to 1999 1011 to 120       892/1385
(64 %)
24 diff
(98.3 %id)
BM753536 stomach .a 1112 to 1655 1 to 541       541/541
(100 %)
2 diff
(99.7 %id)
TI_1948086893   .a 1113 to 1999 1018 to 123       896/1401
(63 %)
19 diff
(98.7 %id)
AA132358   .a 1118 to 1552 1 to 439       439/439
(100 %)
7 diff
(98.5 %id)
BI260652 cervical carcinoma cell line, cervix .a 1138 to 1897 13 to 789       777/789
(98 %)
30 diff
(96.2 %id)
CB150552 cervix, Uterine .a 1156 to 1680 1 to 525       525/525
(100 %)
0 diff
(100 %id)
BM698715 eye, fetal eyes .a 1157 to 1554 1 to 398     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 398/398
(100 %)
0 diff
(100 %id)
BX398635 Placenta Cot 25-normalized .a 1164 to 2131 1 to 963       963/986
(97 %)
27 diff
(97.3 %id)
BQ428411 leiomyosarcoma, uterus .a 1167 to 2051 1 to 899       899/908
(99 %)
33 diff
(96.4 %id)
DN916206   .a 1169 to 1331 1 to 163       163/163
(100 %)
8 diff
(95.1 %id)
CB150349 cervix, Uterine .a 1171 to 1738 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BF794312 lymph, lymphoma, cell line .a 1187 to 1922 1 to 726       731/950
(76 %)
28 diff
(97.1 %id)
BP338277 Spleen .a 1189 to 1771 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CB151012 cervix, Uterine .a 1191 to 1796 1 to 606       606/606
(100 %)
0 diff
(100 %id)
AU137950 placenta .a 1192 to 1968 2 to 783   capped   782/783
(99 %)
12 diff
(98.5 %id)
BP871366 embryonal kidney .a 1198 to 1531 1 to 334       334/334
(100 %)
1 diff
(99.8 %id)
TI_1948086374   .a 1209 to 1999 916 to 121       796/1372
(58 %)
8 diff
(99.5 %id)
BE882054 leiomyosarcoma, uterus .a 1212 to 1946 1 to 722       726/884
(82 %)
28 diff
(96.9 %id)
DT219360 brain .a 1220 to 1848 1 to 629       629/629
(100 %)
2 diff
(99.7 %id)
FN136519 breast carcinoma .a 1225 to 1318 93 to 1     Submitted on the opposite strand 93/95
(97 %)
3 diff
(96.9 %id)
BE535423 cervix .a 1234 to 1939 1 to 697       697/890
(78 %)
22 diff
(97.6 %id)
CA393844 eye, RPE/choroid .a 1247 to 1750 1 to 505       505/505
(100 %)
2 diff
(99.7 %id)
BG742156 skin .a 1250 to 2029 1 to 778       778/778
(100 %)
6 diff
(99.3 %id)
BY995758   .a 1259 to 1955 8 to 704       697/704
(99 %)
7 diff
(99.1 %id)
BM785916 Ascites, stomach .a 1274 to 1854 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
CB134745 Liver .a 1293 to 1890 1 to 598       598/598
(100 %)
1 diff
(99.9 %id)
BP382436 adipose tissue .a 1294 to 1898 1 to 605       605/605
(100 %)
8 diff
(98.7 %id)
BQ421782 epithelioid carcinoma, Pancreas .a 1297 to 2158 1 to 866       866/866
(100 %)
11 diff
(98.8 %id)
BM847501 myeloma .a 1301 to 1847 1 to 547       547/547
(100 %)
0 diff
(100 %id)
BM845318 myeloma .a 1301 to 1551 1 to 251       251/251
(100 %)
0 diff
(100 %id)
BF033208 adenocarcinoma, ovary .a 1306 to 2079 1 to 770       770/891
(86 %)
31 diff
(96.6 %id)
AW937434 denis_drash .a 1317 to 1693 385 to 9     Submitted on the opposite strand 377/385
(97 %)
0 diff
(100 %id)
CD677162 eye, Trabecular meshwork .a 1317 to 1940 1 to 624       624/624
(100 %)
1 diff
(99.9 %id)
BG166807 hypernephroma, cell line, Kidney .a 1371 to 1692 1 to 322       322/322
(100 %)
0 diff
(100 %id)
BQ682053 melanotic melanoma, cell line, skin .a 1375 to 2277 1 to 904       904/906
(99 %)
5 diff
(99.5 %id)
BU196573 melanotic melanoma, cell line, skin .a 1375 to 2241 1 to 873       873/907
(96 %)
10 diff
(98.9 %id)
EC499162 Prostate .a 1393 to 1485 99 to 7       93/99
(93 %)
0 diff
(100 %id)
AU139798 placenta .a 1398 to 2202 2 to 814   fully sequenced, capped   813/813
(100 %)
14 diff
(98.3 %id)
BG253875 adenocarcinoma, cell line, Prostate .a 1409 to 2085 1 to 681       681/683
(99 %)
11 diff
(98.4 %id)
CD579422 brain .a 1410 to 2311 1 to 892       892/929
(96 %)
55 diff
(94.1 %id)
BF799607 colon_ins .a 1418 to 1740 96 to 417       322/417
(77 %)
9 diff
(97.9 %id)
EC450271 Prostate .a 1429 to 1523 102 to 8       95/102
(93 %)
0 diff
(100 %id)
BM697981 eye, fetal eyes .a 1430 to 1896 1 to 467     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 467/467
(100 %)
1 diff
(99.8 %id)
BM702283 eye, optic nerve .a 1466 to 2111 1 to 645   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 645/645
(100 %)
0 diff
(100 %id)
BM827565 stomach .a 1478 to 2029 1 to 552       552/552
(100 %)
1 diff
(99.9 %id)
BQ430646 embryonal carcinoma, cell line, testis .a 1480 to 2338 1 to 869       869/874
(99 %)
18 diff
(98.0 %id)
TI_151796047   .a 1481 to 2106 57 to 686       630/795
(79 %)
17 diff
(97.9 %id)
BG113349 Bone, osteosarcoma, cell line .a 1486 to 2249 1 to 775       775/1092
(70 %)
58 diff
(94.7 %id)
CU456567 epidermis .a 1496 to 2023 536 to 9     Submitted on the opposite strand 528/541
(97 %)
5 diff
(99.1 %id)
BQ644253 hepatocellular carcinoma, cell line, Liver .a 1506 to 2468 13 to 976       964/976
(98 %)
21 diff
(97.9 %id)
CX788944 human embryonic stem cells .a 1506 to 2362 1 to 857       857/857
(100 %)
3 diff
(99.7 %id)
BQ649600 hepatocellular carcinoma, cell line, Liver .a 1508 to 2337 1 to 847       847/961
(88 %)
39 diff
(96.0 %id)
BM806947 lymph, lymphoma, cell line .a 1523 to 2536 1 to 1031       1031/1058
(97 %)
38 diff
(96.5 %id)
BX089324 liver and spleen .a 1529 to 2307 1 to 779       779/787
(98 %)
3 diff
(99.7 %id)
BM556031 duodenal adenocarcinoma, cell line, small intestine .a 1534 to 2438 1 to 915       915/1031
(88 %)
27 diff
(97.4 %id)
FN139802 breast carcinoma .a 1543 to 1616 1 to 73       73/77
(94 %)
5 diff
(93.6 %id)
BE536477 cervix .a 1546 to 2216 1 to 674       674/828
(81 %)
11 diff
(98.7 %id)
BM710638 eye, fetal eyes .a 1552 to 1808 1 to 257     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 257/257
(100 %)
0 diff
(100 %id)
BI089659 cervix .a 1571 to 2307 1 to 739       739/742
(99 %)
10 diff
(98.7 %id)
BG189830   .a 1572 to 2381 1 to 789       789/796
(99 %)
57 diff
(92.9 %id)
EC569821 Prostate .a 1572 to 1671 99 to 1       99/99
(100 %)
1 diff
(99.0 %id)
AA504409 germinal center B cell .a 1573 to 1861 1 to 290       290/290
(100 %)
2 diff
(99.4 %id)
TI_151770383   .a 1589 to 2244 277 to 938       662/1087
(60 %)
19 diff
(98.3 %id)
BG678201 skin, squamous cell carcinoma .a 1597 to 2345 1 to 749       749/749
(100 %)
2 diff
(99.8 %id)
AL570976 placenta, Placenta Cot 25-normalized .a 1638 to 2630 991 to 1       991/991
(100 %)
13 diff
(98.7 %id)
BE395236 endometrium, adenocarcinoma cell line, uterus .a 1655 to 2201 1 to 544       544/549
(99 %)
9 diff
(98.4 %id)
BG252734 adenocarcinoma, cell line, Liver .a 1668 to 2375 1 to 709       709/709
(100 %)
6 diff
(99.2 %id)
AL518886 brain, neuroblastoma, neuroblastoma cells .a 1673 to 2637 960 to 1       960/1044
(91 %)
18 diff
(98.3 %id)
AB015337 brain .a 1679 to 2216 1 to 537       537/537
(100 %)
3 diff
(99.5 %id)
AL572390 placenta, Placenta Cot 25-normalized .a 1681 to 2600 944 to 28       917/944
(97 %)
4 diff
(99.6 %id)
AL553657 placenta, Placenta Cot 25-normalized .a 1681 to 2637 954 to 1       954/957
(99 %)
10 diff
(99.0 %id)
AA029769 uterus .a 1692 to 2199 1 to 507   fully sequenced,   507/507
(100 %)
5 diff
(99.1 %id)
AA280352 germinal center B cell .a 1697 to 1953 1 to 257       257/257
(100 %)
1 diff
(99.7 %id)
AA278168 germinal center B cell .a 1697 to 1896 1 to 200     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 200/200
(100 %)
1 diff
(99.5 %id)
BU945603 mixed (pool of 40 RNAs) .a 1698 to 2464 1 to 773       773/806
(95 %)
12 diff
(98.6 %id)
BM836029 stomach .a 1731 to 2135 1 to 405       405/405
(100 %)
2 diff
(99.6 %id)
BP207372 coronary artery .a 1750 to 2328 1 to 578       578/582
(99 %)
7 diff
(98.8 %id)
TI_149294762   .a 1813 to 2665 940 to 96   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 845/969
(87 %)
12 diff
(98.8 %id)
TI_149298671   .a 1813 to 2665 954 to 113   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 842/949
(88 %)
23 diff
(97.6 %id)
TI_149313388   .a 1813 to 2665 966 to 115   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 852/990
(86 %)
16 diff
(98.4 %id)
TI_154029844   .a 1819 to 2665 920 to 84   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 837/923
(90 %)
16 diff
(98.3 %id)
CN290922 embryonic stem cells, DMSO-treated H9 cellline .a 1822 to 2308 1 to 487       487/487
(100 %)
3 diff
(99.4 %id)
BX434851 brain, fetal brain .a 1836 to 2662 836 to 1       836/863
(96 %)
56 diff
(93.6 %id)
BM748805 Ascites, stomach .a 1836 to 2353 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BU179036 leiomyosarcoma, uterus .a 1850 to 2666 1 to 824       824/879
(93 %)
15 diff
(98.3 %id)
TI_149312208   .a 1872 to 2665 880 to 91   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 790/926
(85 %)
9 diff
(99.1 %id)
BM466834 eye, retinoblastoma .a 1885 to 2668 1 to 783       783/1087
(72 %)
9 diff
(99.2 %id)
BQ773974 Bone, Human Chondrosarcoma Cell Line .a 1885 to 2665 798 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 780/780
(100 %)
4 diff
(99.5 %id)
BU615214 Bone, Human Chondrosarcoma Cell Line .a 1901 to 2665 782 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 764/764
(100 %)
2 diff
(99.8 %id)
BX497137 Liver .a 1902 to 2351 1 to 450       450/450
(100 %)
5 diff
(98.9 %id)
CB146373 Liver .a 1908 to 2477 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
CB241577 Human Lung Epithelial cells, lung .a 1921 to 2665 763 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 745/745
(100 %)
1 diff
(99.9 %id)
BE841822 stomach_normal .a 1928 to 2137 214 to 5       210/214
(98 %)
0 diff
(100 %id)
BU689549 lung .a 1928 to 2665 756 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 738/738
(100 %)
2 diff
(99.8 %id)
BU633033 cell lines, Chondrosarcoma .a 1931 to 2665 753 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 735/735
(100 %)
1 diff
(99.9 %id)
CA442408 Fibrosarcoma .a 1932 to 2665 753 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 735/735
(100 %)
2 diff
(99.8 %id)
BU683394 lung .a 1933 to 2665 751 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 733/733
(100 %)
1 diff
(99.9 %id)
BU608107 Human Lung Epithelial cells, lung .a 1944 to 2665 739 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 721/721
(100 %)
2 diff
(99.8 %id)
CA442321 Fibrosarcoma .a 1945 to 2665 739 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 721/721
(100 %)
4 diff
(99.5 %id)
TI_154128767   .a 1954 to 2665 802 to 91   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 712/712
(100 %)
2 diff
(99.8 %id)
Z19430 leg muscle, skeletal muscle .a 1957 to 2300 344 to 1       344/344
(100 %)
0 diff
(100 %id)
AW946148 lung_tumor .a 1958 to 2083 131 to 8     Submitted on the opposite strand 124/131
(94 %)
0 diff
(100 %id)
AW946250 lung_tumor .a 1958 to 2082 129 to 8     Submitted on the opposite strand 122/129
(94 %)
0 diff
(100 %id)
BM829328 Ascites, stomach .a 1958 to 2504 1 to 546       546/546
(100 %)
1 diff
(99.9 %id)
AA031993 uterus .a 1960 to 2459 1 to 502   fully sequenced,   502/502
(100 %)
3 diff
(99.5 %id)
AA171956   .a 1964 to 2217 1 to 256       256/256
(100 %)
4 diff
(98.5 %id)
AA169653   .a 1965 to 2340 1 to 380   fully sequenced,   380/380
(100 %)
6 diff
(98.5 %id)
N55157 multiple sclerosis lesions .a 1971 to 2159 1 to 189       189/189
(100 %)
1 diff
(99.5 %id)
BM714451 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1973 to 2598 1 to 626       626/626
(100 %)
2 diff
(99.7 %id)
TI_149291356   .a 1975 to 2665 770 to 80   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 691/945
(73 %)
2 diff
(99.8 %id)
BM973989 lung .a 1975 to 2665 709 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 691/707
(97 %)
2 diff
(99.8 %id)
CA417710 Chondrosarcoma Cell line .a 1975 to 2665 709 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 691/691
(100 %)
2 diff
(99.8 %id)
BG286198 bladder, transitional cell papilloma, cell line .a 1987 to 2674 1 to 686       686/729
(94 %)
8 diff
(99.0 %id)
TI_149277688   .a 2002 to 2665 751 to 89   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 663/665
(99 %)
4 diff
(99.4 %id)
BU737093 eye, fetal eyes .a 2011 to 2665 673 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 655/655
(100 %)
1 diff
(99.9 %id)
CF541399 lung .a 2013 to 2665 671 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 653/653
(100 %)
1 diff
(99.9 %id)
BM975385 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 2013 to 2665 671 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 653/653
(100 %)
2 diff
(99.7 %id)
BU677871 lung .a 2022 to 2665 661 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 643/643
(100 %)
4 diff
(99.4 %id)
BU628538 Bone, Enchondroma cell line .a 2022 to 2665 662 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 644/644
(100 %)
1 diff
(99.9 %id)
BU629273 cell lines, Chondrosarcoma .a 2022 to 2665 662 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 644/644
(100 %)
1 diff
(99.9 %id)
AL041443 testis .a 2026 to 2640 615 to 1       615/615
(100 %)
1 diff
(99.9 %id)
BU632365 cell lines, Chondrosarcoma .a 2027 to 2665 657 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 639/639
(100 %)
2 diff
(99.7 %id)
AU157388 placenta .a 2041 to 2665 623 to 1       623/625
(99 %)
18 diff
(97.2 %id)
BU732578 eye, optic nerve .a 2042 to 2665 642 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 624/624
(100 %)
5 diff
(99.2 %id)
CA942968 Pancreas, Purified pancreatic islet .a 2047 to 2666 12 to 631       620/635
(97 %)
2 diff
(99.7 %id)
BE765214 nervous_tumor .a 2071 to 2396 327 to 1       327/327
(100 %)
3 diff
(99.1 %id)
AU154802 ovary, tumor tissue .a 2075 to 2665 590 to 1       590/593
(99 %)
11 diff
(98.2 %id)
DB353939   .a 2078 to 2665 589 to 1       589/591
(99 %)
11 diff
(98.2 %id)
BQ000450 Fibrosarcoma .a 2081 to 2682 620 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 602/602
(100 %)
1 diff
(99.9 %id)
CK903059 Pancreas, Purified pancreatic islet .a 2081 to 2614 1 to 534     Submitted on the opposite strand 534/534
(100 %)
1 diff
(99.9 %id)
BM664958 eye, optic nerve .a 2081 to 2665 603 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 585/585
(100 %)
0 diff
(100 %id)
BU631952 cell lines, Chondrosarcoma .a 2081 to 2665 603 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 585/585
(100 %)
2 diff
(99.7 %id)
BE670038 carcinoid, lung .a 2085 to 2666 585 to 4       582/585
(99 %)
0 diff
(100 %id)
BQ017252 lung, Metastatic Chondrosarcoma .a 2088 to 2665 596 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 578/578
(100 %)
5 diff
(99.2 %id)
BJ990530 hepatoblastoma .a 2106 to 2645 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
AI701163 carcinoid, lung .a 2108 to 2664 557 to 1       557/557
(100 %)
2 diff
(99.7 %id)
CA942732 Pancreas, Purified pancreatic islet .a 2112 to 2664 553 to 1       553/553
(100 %)
1 diff
(99.9 %id)
AU158175 placenta .a 2121 to 2664 546 to 1       546/595
(91 %)
10 diff
(98.4 %id)
AA703268 liver and spleen .a 2123 to 2666 544 to 1       544/544
(100 %)
1 diff
(99.9 %id)
BE349506 malignant melanoma, metastatic to lymphnode, skin .a 2131 to 2665 535 to 1       535/535
(100 %)
0 diff
(100 %id)
DB353525   .a 2134 to 2665 530 to 1       530/530
(100 %)
16 diff
(97.0 %id)
CF349959 placenta .a 2150 to 2663 1 to 514       514/514
(100 %)
2 diff
(99.7 %id)
AV681605 hepatocellular carcinoma .a 2150 to 2665 1 to 516   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 516/516
(100 %)
3 diff
(99.5 %id)
AA977160 pooled germ cell tumors .a 2151 to 2665 515 to 1       515/515
(100 %)
1 diff
(99.9 %id)
AW250751 lung, small cell carcinoma .a 2152 to 2665 526 to 13       514/526
(97 %)
1 diff
(99.9 %id)
BM667356 eye, fetal eyes .a 2158 to 2665 526 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 508/508
(100 %)
1 diff
(99.9 %id)
AI827503 pooled .a 2161 to 2668 510 to 3       508/510
(99 %)
0 diff
(100 %id)
AU158182 placenta .a 2172 to 2668 495 to 1   fully sequenced,   495/495
(100 %)
5 diff
(99.0 %id)
DB551563 hippocampus .a 2176 to 2666 1 to 491     Submitted on the opposite strand 491/497
(98 %)
1 diff
(99.8 %id)
CN290930 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2181 to 2666 1 to 486       486/487
(99 %)
2 diff
(99.6 %id)
AA029770 uterus .a 2182 to 2666 492 to 2   fully sequenced,   491/492
(99 %)
0 diff
(100 %id)
AA877105 Kidney .a 2182 to 2665 494 to 11   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 484/484
(100 %)
1 diff
(99.8 %id)
BU737154 eye, fetal eyes .a 2249 to 2665 435 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 417/431
(96 %)
1 diff
(99.8 %id)
AA132238   .a 2258 to 2666 413 to 4       410/413
(99 %)
0 diff
(100 %id)
AA278400 germinal center B cell .a 2285 to 2665 408 to 28   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 381/381
(100 %)
0 diff
(100 %id)
AA169833   .a 2310 to 2669 360 to 1   fully sequenced,   360/360
(100 %)
2 diff
(99.5 %id)
N50800 multiple sclerosis lesions .a 2357 to 2667 312 to 1       312/321
(97 %)
2 diff
(99.4 %id)
BM667150 eye, fetal eyes .a 2405 to 2665 279 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 261/261
(100 %)
1 diff
(99.7 %id)
AA171744   .a 2419 to 2666 252 to 5       248/252
(98 %)
0 diff
(100 %id)
AA031922 uterus .a 2429 to 2665 237 to 1   fully sequenced,   237/237
(100 %)
1 diff
(99.6 %id)
DA209013 brain .b 1 to 562 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
AK124730 brain .b 10 to 2802 11 to 2803 exact tiling clone, available from FLJ,   2793/2793
(100 %)
4 diff
(99.9 %id)
BP282933 bone marrow .b 155 to 737 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DB447414 testis .b 173 to 607 1 to 434       434/434
(100 %)
1 diff
(99.8 %id)
DB304304 brain .b 2275 to 2802 529 to 1       529/529
(100 %)
2 diff
(99.7 %id)
AA836106 germinal center B cell .b 2318 to 2803 500 to 15       486/500
(97 %)
0 diff
(100 %id)
DB550200 hippocampus .b 2322 to 2804 1 to 483     Submitted on the opposite strand 483/483
(100 %)
1 diff
(99.8 %id)
BF197010 pooled .b 2325 to 2802 489 to 11   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 479/479
(100 %)
1 diff
(99.8 %id)
AA857717 adenocarcinoma, colon .b 2330 to 2803 479 to 6       474/479
(98 %)
0 diff
(100 %id)
AU119212 whole embryo, mainly head .b 2332 to 2802 2 to 472   capped   471/471
(100 %)
1 diff
(99.8 %id)
AW662098 2 pooled high-grade transitional celltumors, genitourinary tract .b 2333 to 2802 470 to 1       470/470
(100 %)
2 diff
(99.6 %id)
DB571081 hypothalamus .b 2338 to 2803 1 to 466     Submitted on the opposite strand 466/473
(98 %)
2 diff
(99.6 %id)
DB522721 testis .b 2343 to 2804 1 to 462     Submitted on the opposite strand 462/462
(100 %)
1 diff
(99.8 %id)
DB512690 testis .b 2378 to 2806 1 to 432     Submitted on the opposite strand 432/432
(100 %)
5 diff
(98.9 %id)
DB546190 hippocampus .b 2378 to 2802 1 to 425   tiling clone, AAA Submitted on the opposite strand 425/425
(100 %)
0 diff
(100 %id)
AI263297 adenocarcinoma, Pancreas .b 2418 to 2802 399 to 15   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
AA642435 germinal center B cell .b 2424 to 2802 413 to 35   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 379/379
(100 %)
0 diff
(100 %id)
DB534616 hippocampus .b 2433 to 2804 1 to 375     Submitted on the opposite strand 375/375
(100 %)
5 diff
(98.7 %id)
AA693705 liver and spleen .b 2448 to 2804 357 to 1       357/357
(100 %)
0 diff
(100 %id)
BF436280 pooled .b 2464 to 2802 359 to 21   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 339/339
(100 %)
0 diff
(100 %id)
T10346   .b 2468 to 2803 339 to 3       337/339
(99 %)
0 diff
(100 %id)
AW449744   .b 2472 to 2802 348 to 18   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 331/331
(100 %)
0 diff
(100 %id)
DB512386 testis .b 2491 to 2804 1 to 314     Submitted on the opposite strand 314/314
(100 %)
15 diff
(95.3 %id)
T16287   .b 2495 to 2802 308 to 1       308/308
(100 %)
0 diff
(100 %id)
AI193292 lung .b 2531 to 2802 284 to 13   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 272/272
(100 %)
0 diff
(100 %id)
AW118415 brain, tumor, 5 pooled (see description) .b 2531 to 2802 272 to 1       272/272
(100 %)
0 diff
(100 %id)
AA553714 breast .b 2536 to 2802 289 to 23   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 267/267
(100 %)
0 diff
(100 %id)
AI862986 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2557 to 2802 256 to 11   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 246/246
(100 %)
0 diff
(100 %id)
AW662050 colon, moderately-differentiated adenocarcinoma .b 2563 to 2802 256 to 17   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 240/240
(100 %)
0 diff
(100 %id)
AI473520 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2566 to 2820 255 to 1       255/255
(100 %)
0 diff
(100 %id)
AW768255 lymph node, lymphoma, follicular mixed small and largecell .b 2576 to 3005 430 to 1   tiling clone,   430/430
(100 %)
0 diff
(100 %id)
BU735601 eye, fetal eyes .b 2592 to 2802 229 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 211/211
(100 %)
0 diff
(100 %id)
AA865810 Kidney .b 2637 to 2801 165 to 1       165/165
(100 %)
0 diff
(100 %id)
AA634073   .b 2659 to 2802 188 to 45   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 144/144
(100 %)
0 diff
(100 %id)
DB467602 hippocampus .c 1 to 465 1 to 468       468/468
(100 %)
5 diff
(99.0 %id)
DB481377 hippocampus .c 1 to 431 1 to 431   tiling clone,   431/431
(100 %)
0 diff
(100 %id)
DB011863 esophageal, tumor tissue .c 17 to 573 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA493901 brain .c 51 to 552 2 to 503   capped   502/502
(100 %)
0 diff
(100 %id)
BM478673 embryonal carcinoma, cell line, testis .c 54 to 626 1 to 576       576/1061
(54 %)
13 diff
(98.8 %id)
CD243538 testis .c 54 to 885 26 to 861   tiling clone,   834/861
(96 %)
12 diff
(98.7 %id)
AW610255 stomach .c 167 to 598 1 to 433       433/433
(100 %)
19 diff
(95.7 %id)
BF203936 muscle, rhabdomyosarcoma .c 766 to 1361 1 to 592   tiling clone,   592/592
(100 %)
7 diff
(98.9 %id)
BG827859 muscle, rhabdomyosarcoma .c 766 to 1412 1 to 649   tiling clone,   649/650
(99 %)
5 diff
(99.3 %id)
AK299514 brain .d 1 to 1457 2 to 1459 P52S L291F N292E K293* tiling clone,   1461/1461
(100 %)
2 diff
(99.9 %id)
DC374309 brain .d 1 to 576 2 to 577       577/577
(100 %)
3 diff
(99.5 %id)
CN290933 embryonic stem cells, DMSO-treated H9 cellline .e 1 to 678 9 to 686   tiling clone,   678/686
(98 %)
7 diff
(99.0 %id)
BQ437070 melanotic melanoma, skin .e 53 to 910 8 to 867   tiling clone,   860/867
(99 %)
12 diff
(98.7 %id)
CB130939 Liver .e 59 to 679 1 to 621       621/621
(100 %)
1 diff
(99.9 %id)
BM846934 myeloma .e 60 to 576 1 to 516       516/516
(100 %)
2 diff
(99.7 %id)
BQ437162 melanotic melanoma, skin .e 82 to 896 1 to 819       819/821
(99 %)
5 diff
(99.4 %id)
BM475452 eye, retinoblastoma .e 87 to 822 1 to 738       738/1104
(66 %)
12 diff
(99.0 %id)
BU177855 melanotic melanoma, skin .e 87 to 900 1 to 825   tiling clone,   825/929
(88 %)
20 diff
(97.9 %id)
BE883837 leiomyosarcoma, uterus .e 94 to 823 1 to 731   tiling clone,   731/903
(80 %)
24 diff
(97.4 %id)
BE778787 eye, retinoblastoma .e 96 to 801 1 to 704       704/704
(100 %)
17 diff
(97.6 %id)
BG771566 testis .f 1 to 758 1 to 761   tiling clone,   759/768
(98 %)
9 diff
(98.9 %id)
BG772084 testis .f 19 to 760 1 to 740       740/826
(89 %)
8 diff
(99.1 %id)
BI464816 testis .f 19 to 768 1 to 758       758/854
(88 %)
22 diff
(97.5 %id)
BG723315 testis .f 28 to 731 10 to 713       704/714
(98 %)
10 diff
(98.6 %id)
DA958822 Spleen .f 35 to 585 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BI544233 brain, hippocampus .f 36 to 721 1 to 686       686/686
(100 %)
6 diff
(99.2 %id)
TI_44000268   .f 37 to 721 122 to 806       685/806
(84 %)
9 diff
(98.9 %id)
BE884902 leiomyosarcoma, uterus .f 42 to 758 1 to 721       721/757
(95 %)
16 diff
(97.9 %id)
BG331409 large cell carcinoma, lung .f 46 to 731 1 to 689       689/869
(79 %)
27 diff
(96.9 %id)
DA295313 hippocampus .f 53 to 638 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA942376 Spleen .f 53 to 622 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
BF797548 lymph, lymphoma, cell line .f 64 to 719 1 to 664       664/895
(74 %)
18 diff
(98.0 %id)
DA781631 brain .f 71 to 644 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA182047 amygdala .f 73 to 605 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA941535 Spleen .f 73 to 679 2 to 608   capped   607/607
(100 %)
2 diff
(99.7 %id)
DB261128 uterus .f 73 to 634 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BX438259 neuroblastoma .f 74 to 920 1 to 846   tiling clone,   846/846
(100 %)
4 diff
(99.6 %id)
DA482451   .f 76 to 643 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BU187062 eye, retinoblastoma .f 76 to 895 1 to 825   tiling clone,   825/911
(90 %)
18 diff
(98.1 %id)
DA747841   .f 76 to 632 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
CN290929 embryonic stem cells, cell lines H1, H7, andH9 .f 95 to 671 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
DN994019 brain, whole brain .f 169 to 760 9 to 600       592/600
(98 %)
7 diff
(98.9 %id)
AW393521 stomach .f 192 to 690 1 to 496       496/505
(98 %)
13 diff
(97.5 %id)
AW836711 leiomios .f 198 to 623 7 to 433       427/433
(98 %)
10 diff
(97.7 %id)
BI048055 stomach .f 226 to 690 468 to 6       463/468
(98 %)
4 diff
(99.2 %id)
BG978120 colon_ins .g 1 to 430 1 to 431   tiling clone,   431/431
(100 %)
17 diff
(96.1 %id)
BE779340 eye, retinoblastoma .g 411 to 1127 1 to 719   tiling clone,   719/779
(92 %)
14 diff
(98.3 %id)
AW391744 stomach .h 1 to 545 569 to 22 N12Y K33I N36Y R38S K39I ... tiling clone,   547/571
(95 %)
14 diff
(97.6 %id)
DA626588 Kidney .i 1 to 575 2 to 581 G27L I28A G29S C30A E31C ... tiling clone, capped   580/580
(100 %)
6 diff
(99.0 %id)
DW465002 Liver .j 1 to 344 10 to 360 L45W Q65E R93K V94Y L95K tiling clone,   351/360
(97 %)
11 diff
(97.0 %id)
BY996979   .k-u 1 to 601 10 to 610   tiling clone,   601/610
(98 %)
6 diff
(99.1 %id)
CN282054 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k-u 77 to 704 1 to 628   tiling clone,   628/628
(100 %)
4 diff
(99.4 %id)
CV350877 colon .k-u 704 to 1196 28 to 522 S7R N10E S11Q S12F W13L ... tiling clone,   495/530
(93 %)
24 diff
(95.5 %id)
AW265702 normal squamous epithelium, tongue .k-u 1006 to 1433 436 to 9   tiling clone,   428/450
(95 %)
0 diff
(100 %id)
AW265652 normal squamous epithelium, tongue .k-u 1074 to 1433 381 to 22       360/381
(94 %)
0 diff
(100 %id)
BM505248 Pancreas, Purified pancreatic islet .l-u 1 to 414 1 to 414   tiling clone, Submitted on the opposite strand 414/414
(100 %)
2 diff
(99.6 %id)
CB250547 Human Lung Epithelial cells, lung .l-u 73 to 606 550 to 17 A20S AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 534/553
(96 %)
3 diff
(99.5 %id)
CA849094 Pancreas, Purified pancreatic islet .l-u 178 to 718 541 to 1 A11P K18N A23V T28P   Submitted on the opposite strand 541/541
(100 %)
8 diff
(98.6 %id)
CK822567 Pancreas, Purified pancreatic islet .l-u 193 to 772 580 to 1       580/589
(98 %)
5 diff
(99.2 %id)
BM509648 Pancreas, Purified pancreatic islet .l-u 352 to 782 447 to 17   tiling clone, Submitted on the opposite strand 431/458
(94 %)
0 diff
(100 %id)
AA352365   .l-u 357 to 606 1 to 250       250/250
(100 %)
1 diff
(99.6 %id)
BG223169 nasopharynx, normal epithelium .l-u 419 to 741 43 to 365       323/365
(88 %)
6 diff
(98.4 %id)
DA095539 cerebellum .m-u 1 to 548 2 to 549 M27T tiling clone, capped   548/548
(100 %)
2 diff
(99.7 %id)
CV365937 nervous_normal .m-u 134 to 329 27 to 218   tiling clone,   192/218
(88 %)
7 diff
(96.8 %id)
CN290931 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 1 to 171 1 to 171 exact tiling clone,   171/171
(100 %)
1 diff
(99.5 %id)
BP283939 bone marrow Gene UBA2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l-u, .m-u, .n Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI